Jul. 10 at 11:43 AM
$CNMD is holding strong — here’s why it still deserves a spot in your portfolio 👇
Recurring revenues are solid, margins are improving, and surgical product growth continues — even with supply and cybersecurity headwinds.
Full breakdown here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570795_TEASER